/Companies

Carmell

OTC: XAGE

Pittsburgh, US · Founded 2021 · Delaware corporation · 1 known investors

Find your way into Carmell

Sign up to see every warm intro you have to Carmell

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the Carmell team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

A cosmetic skincare and haircare company that develops exosome-based and platelet-derived products for professional care providers and retail consumers seeking anti-aging and regenerative solutions. The company manufactures Elevai Exosomes skincare and haircare lines—which contain nano-sized vesicles derived from cultured stem cells—and Carmell Secretome skincare products made from growth factors extracted from allogeneic human platelets, all produced in U.S. facilities under strict regulatory standards.

Founders & leadership

RS
Rajiv S. ShuklaExecutive
BC
Bryan CassadayExecutive
JA
Janakiram AjjarapuChairman, Chief Executive Officer and Class III Director
DA
David AndersonNamed on SEC filing

Board

PS
Patrick SturgeonBoard director
SF
Scott FrischBoard director
KB
Kendra Bracken-FergusonBoard director
RU
Richard UptonBoard director
GS
Gilles SpenlehauerBoard director
KG
Kathryn GregoryBoard director

Investors · 1

Reported raises · per SEC filings

Form D private placements

$6M disclosed across 4 rounds · 2024–2026

▶$200KraisedMar 2026 · 1 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Rajiv S. ShuklaExecutive Officer, Director
  • Kathryn GregoryDirector
  • Janakiram AjjarapuExecutive Officer, Director
  • Patrick SturgeonDirector
  • Scott FrischDirector
  • Bryan CassadayExecutive Officer
  • Gilles SpenlehauerDirector
  • Richard UptonDirector
Offering amount
$200K
Amount sold
$200K
First sale
Mar 2026
Incorporated
Corporation, Delaware, 2021
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$975.5KraisedJan 2025 · 1 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Richard UptonDirector
  • Scott FrischDirector
  • Bryan CassadayExecutive Officer
  • Rajiv ShuklaExecutive Officer, Director
  • Kathryn GregoryDirector
  • Patrick SturgeonDirector
  • Gilles S. SpenlehauerDirector
Offering amount
$1.1M
Amount sold
$975.5K
First sale
Jan 2025
Incorporated
Corporation, Delaware, 2021
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$1.9MraisedJan 2025 · 14 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Scott FrischDirector
  • Kendra Bracken-FergusonExecutive Officer
  • Richard UptonDirector
  • Patrick SturgeonDirector
  • Gilles SpenlehauerDirector
  • Kathryn GregoryDirector
  • Rajiv S. ShuklaExecutive Officer, Director
  • Bryan CassadayExecutive Officer
Offering amount
$3.7M
Amount sold
$1.9M
Sales commissions
$127.9K
Placement agents
Arcadia Securities, LLC
First sale
Jan 2025
Incorporated
Corporation, Delaware, 2021
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$3MraisedApr 2024 · 19 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Gilles SpenlehauerDirector
  • Kathryn GregoryDirector
  • Richard UptonDirector
  • Patrick SturgeonDirector
  • David AndersonDirector
  • Rajiv S. ShuklaExecutive Officer, Director
Offering amount
$3M
Amount sold
$3M
Sales commissions
$212.2K
Placement agents
Arcadia Securities, LLC
First sale
Apr 2024
Incorporated
Corporation, Delaware, 2021
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Frequently asked questions

What does Carmell do?
A cosmetic skincare and haircare company that develops exosome-based and platelet-derived products for professional care providers and retail consumers seeking anti-aging and regenerative solutions. The company manufactures Elevai Exosomes skincare and haircare lines—which contain nano-sized vesicles derived from cultured stem cells—and Carmell Secretome skincare products made from growth factors extracted from allogeneic human platelets, all produced in U.S. facilities under strict regulatory standards.
Who are Carmell's investors?
Carmell's investors include Pittsburgh Life Sciences Greenhouse.
How much funding has Carmell raised?
Carmell has disclosed $6M raised across 4 rounds.
Where is Carmell headquartered?
Carmell is headquartered in Pittsburgh, US.